Longevity in practice

Bryan Johnson Blueprint: the parts with evidence and the parts with a price tag

The protocol is a genuine act of discipline and a supplement catalogue at the same time. Separating those two things is most of the work of reading it.

Bryan Johnson Blueprint: the parts with evidence and the parts with a price tag — illustrated overview

What the Bryan Johnson Blueprint protocol actually contains

The published protocol is unusually detailed: a fixed wake time, a long morning workout mixing strength, cardio and flexibility, a compressed eating window with the final meal in the early afternoon, an early and rigidly consistent bedtime, and a supplement schedule running to dozens of items.[1] On top of that sits an extensive testing program, including regular bloodwork, imaging and epigenetic clock measurements.

It is worth stating plainly that the discipline involved is real. Very few people sustain a consistent sleep schedule and daily training for years. That part is not the problem.

The structure that makes results uninterpretable

Limited evidence The protocol is an n-of-1 self-experiment with no control group, no blinding, hundreds of simultaneous variables and a design that changes whenever its participant decides to change it.[2] Every one of those is fatal to attribution on its own, and they are present together.

Consider what that means in practice. If a marker improves, the cause could be the diet, the training, the sleep, the absence of alcohol, one of the dozens of supplements, regression to the mean, measurement noise, or the fact that someone measuring themselves constantly behaves differently. The protocol cannot tell you which, and neither can anyone reading it.

Which parts have real evidence

A surprising amount of it, once you separate the components. Regular sleep timing, daily aerobic and resistance exercise, a plant-heavy diet, and avoiding alcohol are among the best-supported health behaviors in existence, with population-scale evidence behind each. Creatine, one of the few supplements in the stack, has genuinely strong data for muscle and possibly cognitive benefit.[3]

What those items share is that they are free or nearly free, and that none of them is novel. The protocol's contribution is the consistency, not the discovery. Our guide to what the supplement evidence actually supports applies the same filter across the wider category.

Which parts do not

The long tail of the supplement stack is where the evidence thins out fast. Many entries rest on cell studies or mouse work, several have known bioavailability problems, and a few have been tested in humans with disappointing results. Large trials of individual supplements have repeatedly found less than expected, including the vitamin D and omega-3 arms of a very large randomized trial that reported no reduction in the primary endpoints.[4]

The imaging and testing schedule has a similar problem in a different form. Screening a healthy person without a clinical indication produces incidental findings that require follow-up, and there is no evidence that surveillance at that intensity improves outcomes in people who feel well.

The rapamycin decision

Johnson took rapamycin for several years and then publicly stopped, reporting that the side effects he experienced outweighed any benefit he could measure. Given his commitment to the compound and the visibility of the reversal, that is a genuinely useful data point.

It also aligns with where the evidence sits. Reviews of off-label use in healthy adults have concluded the clinical picture is insufficient to support routine use, and the risk profile is real even at intermittent doses.[5] [6] Our page on what actually changes at longevity doses covers that, and our main evidence guide covers the benefit side.

What the biological age numbers mean

The protocol leans heavily on epigenetic clocks and organ-age estimates. These are legitimate research tools built by regressing DNA methylation patterns against chronological age and health outcomes.[7] They are also noisy at the individual level, sensitive to short-term factors, and not validated as outcomes that predict how long a particular person will live.

So a favorable clock reading is a favorable clock reading. It is not a demonstration that aging has been slowed, and it certainly does not identify which of several hundred interventions produced it. Our page on what biological age tests can and cannot tell you goes through the measurement problem in detail.

You can split the same sample, run it twice, and get upwards of eight years difference in your epigenetic age.

Morgan Levine, PhD biologist of aging; creator of the PhenoAge epigenetic clock FoundMyFitness, 2022

The conflict nobody states plainly

Blueprint is a company that sells the supplements described in the protocol. That does not make the protocol dishonest, and it does make it a document with a commercial function. When the same page is both the record of an experiment and the storefront for its inputs, the incentive to keep items on the list is structural rather than personal.

Read it as you would read any manufacturer's account of its own products: worth reading, not sufficient on its own.

If they're not the hundred-billionaire Nobel Prize winner, don't buy anything from them.

Dr Saul Newman, PhD demographer, UCL; 2024 Ig Nobel Prize in Demography Dr Karan Rajan podcast, 2025

What to actually take from it

The useful lesson from the Bryan Johnson Blueprint project is not the stack. It is that consistency at the boring things, sustained for years and actually measured, is achievable and probably does more than any supplement in the catalogue.

The hallmarks framework that underpins most of these claims makes the same point when applied honestly: mechanisms are cheap, demonstrations are expensive, and almost nothing on a supplement shelf has one.[8] Our explainer on the hallmarks of aging sets out that standard.

Frequently asked questions

What is Bryan Johnson's Blueprint diet?

A calorie-restricted, plant-heavy, largely vegan pattern eaten on a compressed schedule, with the last meal in the early afternoon. It is high in vegetables, legumes, nuts and olive oil, and excludes alcohol entirely. The diet is the least exotic and best-evidenced part of the whole protocol.

Is Blueprint owned by Bryan Johnson?

Yes. Blueprint is both his personal protocol and his supplement company, and the two share a name and a website. That structure means the published protocol is also a product catalogue, which is worth holding in mind while reading it.

How much does Bryan Johnson's blueprint cost?

By his own accounts the full personal version has run to roughly two million dollars a year, including staff, imaging and continuous testing. The consumer version costs whatever the supplement bundle costs. Those are not the same thing, and the results attributed to the first cannot be bought with the second.

Is Bryan Johnson's blueprint worth it?

As a protocol to copy, mostly not. The parts with real evidence, sleep regularity, exercise, a plant-heavy diet, no alcohol, are free. The parts that cost money are the parts with the least evidence, and none of it has been tested against a control.

Does Bryan Johnson still take rapamycin?

No. He publicly stopped after roughly five years, reporting that the side effects he experienced outweighed any benefit he could measure. Coming from the most committed self-experimenter in the field, that is a more useful data point than most of what he publishes.

Does Bryan Johnson take creatine?

Creatine appears in his published protocol and in the products sold under the same brand. It is one of the few supplements in the stack with genuinely strong evidence, though that evidence is about muscle and possibly cognition rather than lifespan.

How many supplements does the protocol include?

Dozens, and the list changes. That variability is itself informative: a protocol revised continuously by its only participant cannot attribute any outcome to any component, because nothing is ever held constant.

Does the protocol actually make him age slower?

He reports epigenetic clock readings and organ-specific age estimates suggesting slower aging. Those measures are research tools with meaningful variability, they respond to short-term factors, and no clock has been validated as an outcome that predicts individual longevity.

What is the strongest criticism of Blueprint?

That it cannot generate knowledge. One person, no control group, hundreds of simultaneous interventions, outcomes measured by tools that were not designed to score individuals. Any result is uninterpretable, which is a design problem rather than an effort problem.

Is any of it worth copying?

Several things. Consistent sleep timing, daily exercise including both strength and cardio, a mostly plant diet, no alcohol, and actually measuring standard blood markers. None of that is novel and all of it is well supported.

What should someone skip?

The long tail of supplements with no human outcome data, the expensive imaging without a clinical indication, and anything justified by a mechanism rather than a result. That covers a large share of the spending.

Does he use prescription drugs?

The protocol has included prescription items over time, and their composition has changed, including the rapamycin discontinuation. Any prescription element requires a physician, which is a hard limit on how much of this anyone can copy.

Is the biological age claim meaningful?

Partly. Some of his measured markers genuinely are better than population averages for his age, which is what you would expect from years of disciplined exercise, sleep and diet. Attributing them to the supplement stack rather than to those basics is the unsupported leap.

What is the honest summary?

A disciplined person doing several well-evidenced things extremely consistently, plus a large number of unevidenced things, selling the combination. The discipline is real and probably beneficial. The attribution is unresolvable by design.

References

  1. Blueprint protocol (self-published). Bryan Johnson.Primary/self-published source; n-of-1, not peer-reviewed.
  2. Rapamycin for longevity: the pros, the cons, and future perspectives. Roark KM, Iffland PH. Frontiers in Aging 2025;6:1628187.Peer-reviewed review, cited 31 times.
  3. What is the clinical evidence to support off-label rapamycin therapy in healthy adults?. Hands SL, Lustgarten MS, Frame AA, Rosen CJ. Aging (Albany NY) 2025.
  4. DNA methylation age of human tissues and cell types. Horvath S. Genome Biology 2013;14:R115.
  5. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation. Kreider RB et al. Journal of the International Society of Sports Nutrition 2017;14:18.
  6. Hallmarks of aging: an expanding universe. López-Otín C et al. Cell 2023;186(2):243–278.Updated framework — twelve hallmarks.
  7. Vitamin D supplements and prevention of cancer and cardiovascular disease. Manson JE et al. New England Journal of Medicine 2019 (VITAL; cited 2,159).25,871 participants, median 5.3 years: vitamin D did not lower the incidence of invasive cancer or cardiovascular events versus placebo.

Own a longevity or health brand?

Rapamycin.store publishes sponsored and guest posts on an aged, topically-relevant domain, and offers display advertising. Tell us what you want to promote and we'll send our current options.

Work with us